Last Updated: February 3, 2011
Products Affected - Description
Mebaral tablets, Lundbeck
32 mg tablets, 250 count (NDC 67386-0801-02)
Reason for the Shortage
- Lundbeck has discontinued Mebaral tablets in all sizes and strengths as a business decision.
- There are no other manufacturers of mephobarbital tablets.
Estimated Resupply Dates
Lundbeck has discontinued Mebaral tablets. Supply should be depleted sometime in late-2011.
Implications for Patient Care
Do not start new patients on mephobarbital tablets. Healthcare providers should start transitioning patients to other medications since supply will be depleted in the next few months.
February 3, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.